D. Lambert

Patrice D Cani, A. Makriyannis, Pauline Bottemanne, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice[S]

M. Maillot, F. Destaillats, J. Martin, 2011, Journal of Lipid Research.

Radiosynthesis, in vitro and in vivo evaluation of 123I-labeled anandamide analogues for mapping brain FAAH.

F. de Vos, L. Wyffels, D. Lambert, 2009, Bioorganic & medicinal chemistry.

Synthesis, in vitro and in vivo evaluation, and radiolabeling of aryl anandamide analogues as candidate radioligands for in vivo imaging of fatty acid amide hydrolase in the brain.

F. de Vos, L. Wyffels, G. Muccioli, 2009, Journal of medicinal chemistry.

A second N-acylethanolamine hydrolase in mammalian tissues

N. Ueda, K. Tsuboi, D. Lambert, 2005, Neuropharmacology.

Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide

C. Fowler, G. Tiger, S. Vandevoorde, 2001, British journal of pharmacology.

beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.

J. Marchand-Brynaert, C. Michaux, G. Muccioli, 2009, Journal of medicinal chemistry.

Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.

G. Scriba, J. Poupaert, J. Wouters, 2006, Journal of medicinal chemistry.

Allergic Contact Dermatitis and the Endocannabinoid System: From Mechanisms to Skin Care

D. Lambert, 2007, ChemMedChem.

1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.

G. Scriba, J. Poupaert, J. Wouters, 2005, Journal of medicinal chemistry.

Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation

Patrice D Cani, N. Delzenne, G. Muccioli, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.

C. Baudelet, B. Gallez, D. Lambert, 1996, Magnetic resonance imaging.

Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.

P. Depreux, J. Poupaert, J. Goossens, 2007, Journal of medicinal chemistry.

The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1‐ and FAAH‐independent mechanisms

G. Muccioli, D. Lambert, B. Bosier, 2013, British journal of pharmacology.

Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism

B. Gallez, G. Muccioli, D. Lambert, 2011, PloS one.

Synthesis and anticonvulsant activity of N,N‐phthaloyl derivatives of central nervous system inhibitory amino acids

G. Scriba, J. Wouters, D. Lambert, 2001, Archiv der Pharmazie.

Synthesis and Anticonvulsant Activity of N‐Benzyloxycarbonyl‐Amino Acid Prodrugs of Phenytoin

G. Scriba, D. Lambert, 1999, The Journal of pharmacy and pharmacology.

Anticonvulsant profile of 4-amino-(2-methyl-4-aminophenyl)benzamide in mice and rats.

J. Poupaert, D. Lambert, M. Kanyonyo, 1998, Pharmacology & toxicology.

Anticonvulsant Activity of Pyrid‐3‐yl‐Sulfonyl Ureas and Thioureas

J. Poupaert, B. Masereel, J. Dogné, 1997, Epilepsia.

Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogue.

O. Diouf, J. Poupaert, J. Stables, 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Bioavailability and anticonvulsant activity of 2-cyanoguanidinophenytoin, a structural analogue of phenytoin.

G. Scriba, B. Masereel, B. Gallez, 1996, Journal of pharmaceutical sciences.

Anticonvulsant Activity of Phenytoin‐lipid Conjugates, a New Class of Phenytoin Prodrugs

G. Scriba, J. Poupaert, D. Lambert, 1995, The Journal of pharmacy and pharmacology.

Bioavailability and anticonvulsant activity of a monoglyceride-derived prodrug of phenytoin after oral administration to rats.

G. Scriba, J. Poupaert, D. Lambert, 1995, Journal of pharmaceutical sciences.

Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding

G. Bormans, C. Casteels, K. Van Laere, 2010, Synapse.

Synthesis and Pharmacological Properties of 2-[S-Acetylthiorphan]-l,3-diacylaminopropan-2-ol Derivatives as Chimeric Lipid Drug Carriers Containing an Enkephalinase Inhibitor

J. Poupaert, D. Lambert, P. Dumont, 1995, Pharmaceutical Research.

3-Alkyl-(5,5'-diphenyl)imidazolidineiones as new cannabinoid receptor ligands.

J. Poupaert, E. Hermans, D. Lambert, 1999, Bioorganic & medicinal chemistry letters.

A high yield synthesis of phenytoin and related compounds using microwave activation

Fern, J. Poupaert, G. Muccioli, 2011 .

Bioavailability of Phenytoin and Anticonvulsant Activity after Oral Administration of Phenytoin-bis-hydroxyisobutyrate to Rats

G. Scriba, D. Lambert, 1997, Pharmaceutical Research.

A rapid and efficient microwave-assisted synthesis of hydantoins and thiohydantoins

G. Scriba, J. Poupaert, B. Norberg, 2003 .

Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding: An In Vivo Micro-PET Study in the Rat Using [18F]MK-9470

G. Bormans, K. Laere, C. Casteels, 2010, Journal of Molecular Neuroscience.

Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.

E. Hermans, D. Lambert, S. J. Govaerts, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.

P. Chavatte, A. Lemoine, P. Desreumaux, 2013, Bioorganic & medicinal chemistry.

4-Oxo-1,4-dihydropyridines as selective CB₂ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.

P. Chavatte, P. Desreumaux, M. Djouina, 2012, Journal of medicinal chemistry.

Checking the integrity of albumin after pasteurisation: a fluorescent assay for quantitating monomeric albumin using anthroyloxy-fatty acids analogs.

B. Gallez, D. Lambert, 1998, Journal of biochemical and biophysical methods.

Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB1 cannabinoid receptor ligands and potential antagonists: Synthesis, lipophilicity, affinity, and molecular modeling : additions and corrections

G. Bouchard, P. Carrupt, B. Testa, 2002 .

Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling.

G. Bouchard, P. Carrupt, B. Testa, 2002, Journal of medicinal chemistry.

Versatile access to benzhydryl-phenylureas through an unexpected rearrangement during microwave-enhanced synthesis of hydantoins.

G. Scriba, J. Poupaert, B. Norberg, 2003, Organic letters.

New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.

P. Chavatte, P. Desreumaux, M. Djouina, 2011, Bioorganic & medicinal chemistry.

Search for monoglyceride lipase inhibitors: synthesis and screening of arylthioamides derivatives

J. Poupaert, N. Draoui, G. Muccioli, 2009, Medicinal Chemistry Research.

N-Hydroxy-6-(5-Nitro- Naphtalimide)-Hexanamide Inhibits Lysine Deacetylation, Mitigates Angiogenesis and Reduces Tumor Growth

A. Noël, P. Delvenne, J. Wouters, 2015 .

Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors.

Y. Schneider, J. Rees, G. Muccioli, 2010, European journal of medicinal chemistry.

Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.

J. Poupaert, G. Muccioli, D. Lambert, 2009, Journal of medicinal chemistry.

Microwave-assisted four-component reaction for the synthesis of a monothiohydantoin inhibitor of a fatty acid amide hydrolase

M. Shipman, G. Muccioli, D. Lambert, 2008 .

Comparative HPLC enantioseparation of new chiral hydantoin derivatives on three different polysaccharide type chiral stationary phases.

G. Scriba, D. Lambert, B. Chankvetadze, 2002, Journal of pharmaceutical and biomedical analysis.

Current knowledge on the antagonists and inverse agonists of cannabinoid receptors.

G. Muccioli, D. Lambert, G G Muccioli, 2005, Current medicinal chemistry.

Substituted 5,5'-diphenyl-2-thioxoimidazolidin-4-one as CB1 cannabinoid receptor ligands: synthesis and pharmacological evaluation.

G. Scriba, J. Poupaert, J. Wouters, 2005, Journal of medicinal chemistry.

Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis.

G. Muccioli, D. Lambert, Marion Feledziak, 2012, Recent patents on CNS drug discovery.

Design and synthesis of 3-acyl-2(3H)-benzoxazolone and 3-acyl-2(3H)-benzothiazolone derivatives

J. Poupaert, C. McCurdy, D. Lambert, 2011 .

Synthesis, characterization and anti-trypanosomal activity of R-(-)carvone and arylketones-thiosemi carbazones and toxicity against Artemia salina Leach

J. Poupaert, V. Hannaert, J. Quetin-Leclercq, 2011 .

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

C. Fowler, D. Lambert, 2005, Journal of medicinal chemistry.

Binding mode of new (thio)hydantoin inhibitors of fatty acid amide hydrolase: comparison with two original compounds, OL-92 and JP104.

J. Wouters, C. Michaux, G. Muccioli, 2006, Bioorganic & medicinal chemistry letters.

Structure–activity relationship of phenytoinergic antiepileptic drugs related to ameltolide

J. Poupaert, C. McCurdy, G. Chevé, 2007, Medicinal Chemistry Research.

CoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl‐CoA β‐oxidation

L. Vallée, J. Vamecq, M. Fontaine, 1993, FEBS letters.

Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.

C. Fowler, S. Vandevoorde, D. Lambert, 2003, Journal of medicinal chemistry.

Chemoresistance to Valproate Treatment of Bovine Leukemia Virus-Infected Sheep; Identification of Improved HDAC Inhibitors

J. Wouters, L. Willems, D. Lambert, 2012, Pathogens.

The endocannabinoid system links gut microbiota to adipogenesis

F. Bäckhed, D. Naslain, Patrice D Cani, 2010, Molecular systems biology.

Targeting of Drug to the Hepatocytes by Fatty Acids. Influence of the Carrier (Albumin or Galactosylated Albumin) on the Fate of the Fatty Acids and Their Analogs

P. Buc-Calderon, B. Gallez, D. Lambert, 2004, Pharmaceutical Research.

Synthesis and distribution of tritiated N,N'-dibenzoyl-1,3-diaminopropan-2-ol.

B. Gallez, D. Lambert, 1996 .

Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.

J. Poupaert, B. Masereel, J. Stables, 1998, Journal of medicinal chemistry.

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

T. van de Wiele, D. Naslain, Patrice D Cani, 2009, Gut.

Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.

Philippe Chavatte, Amaury Farce, P. Depreux, 2006, Journal of medicinal chemistry.

Synthesis and activity of 1,3,5-triphenylimidazolidine-2,4-diones and 1,3,5-triphenyl-2-thioxoimidazolidin-4-ones: characterization of new CB1 cannabinoid receptor inverse agonists/antagonists.

G. Scriba, J. Poupaert, J. Wouters, 2006, Journal of medicinal chemistry.

Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth.

J. Poupaert, G. Muccioli, D. Lambert, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Synthesis and pharmacological evaluation of antioxidant chalcone derivatives of 2 ( 3 H )-benzoxazolones

J. Poupaert, C. McCurdy, D. Lambert, 2009 .

Synthesis and pharmacological evaluation of antioxidant chalcone derivatives of 2(3H)-benzoxazolones

J. Poupaert, C. McCurdy, D. Lambert, 2009, Medicinal Chemistry Research.

The Multiple Pathways of Endocannabinoid Metabolism: A Zoom Out

S. Vandevoorde, D. Lambert, 2007, Chemistry & biodiversity.

Focus on the three key enzymes hydrolysing endocannabinoids as new drug targets.

S. Vandevoorde, D. Lambert, 2005, Current pharmaceutical design.

Preliminary studies about novel strategies to reverse chemoresistance to adriamycin regarding glutathione metabolism, peroxisomal and extraperoxisomal hydroperoxide and valproic acid metabolic pathways

L. Vallée, J. Poupaert, J. Vamecq, 1993, Biology of the cell.

The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action

C. Bouzin, B. Gallez, G. Muccioli, 2012, BMC Cancer.

‘Entourage’ effects of N‐acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide‐induced vanilloid receptor activation and upon anandamide metabolism

C. Fowler, S. Vandevoorde, D. Smart, 2002, British journal of pharmacology.

Molecular Identification of N-Acetylaspartylglutamate Synthase and β-Citrylglutamate Synthase*

F. Opperdoes, F. Collard, J. Poupaert, 2010, The Journal of Biological Chemistry.

A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison

J. Wouters, D. Lambert, G. Labar, 2007, Amino Acids.

Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.

G. Muccioli, D. Lambert, Nicolas Matuszak, 2009, Journal of medicinal chemistry.

CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay

G. Muccioli, D. Lambert, G. Labar, 2008, Chembiochem : a European journal of chemical biology.

An unprecedented reversible mode of action of β-lactams for the inhibition of human fatty acid amide hydrolase (hFAAH).

C. Michaux, D. Lambert, Marion Feledziak, 2013, European journal of medicinal chemistry.

Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2‐Arachidonoylglycerol Signaling

J. Wouters, G. Muccioli, D. Lambert, 2007, Chembiochem : a European journal of chemical biology.

Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.

N. Ueda, K. Tsuboi, Y. Okamoto, 2005, Biochimica et biophysica acta.

N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.

N. Ueda, K. Tsuboi, S. Vandevoorde, 2004, The Biochemical journal.

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors.

N. Delzenne, E. Hermans, P. Sonveaux, 1999, Biochimica et biophysica acta.

Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling

J. Ferrer, J. Wouters, F. Borel, 2010, Chembiochem : a European journal of chemical biology.

PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue.

L. Wyffels, G. Muccioli, D. Lambert, 2010, Nuclear medicine and biology.

Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro

S. Vandevoorde, D. Lambert, K. Jonsson, 2007, British journal of pharmacology.

Differential modulation of AP‐1‐ and CRE‐driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor

E. Hermans, D. Lambert, B. Bosier, 2008, British journal of pharmacology.

Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells

E. Cudaback, N. Stella, G. Muccioli, 2007, The Journal of Neuroscience.

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

P. Chavatte, P. Desreumaux, M. Djouina, 2015, ACS medicinal chemistry letters.

Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.

E. Hermans, D. Lambert, B. Bosier, 2009, Biochemical pharmacology.

Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.

G. Bormans, R. Busson, K. Van Laere, 2008, Nuclear medicine and biology.

Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors.

E. Hermans, G. Muccioli, D. Lambert, 2004, European journal of pharmacology.

Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.

D. Lambert, E. Tschirhart, J. Bueb, 2001, Biochimica et biophysica acta.

Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line

Sébastien Tilleux, E. Hermans, M. Najimi, 2007, Journal of neurochemistry.

Insight into the medicinal chemistry of the endocannabinoid hydrolase inhibitors.

J. Poupaert, D. Lambert, C. N. Kapanda, 2013, Current medicinal chemistry.

Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E‐115 cells

E. Hermans, D. Lambert, B. Bosier, 2008, FEBS letters.

Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: investigation of the target residues and comparison with octhilinone.

D. Lambert, G. Labar, Bouazza Es Saadi, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.

J. Poupaert, G. Muccioli, D. Lambert, 2012, Journal of medicinal chemistry.

Anticonvulsant activity of ester- and amide-type lipid conjugates of glycine and N-benzyloxycarbonylglycine

G. Scriba, J. Poupaert, D. Lambert, 1996 .

Cannabis and Endocannabinoids: ‘The Old Man and the Teenagers’

D. Lambert, 2007, Chemistry & biodiversity.

Comparison of e ects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism

C. Fowler, D. Smart, D. Lambert, 2002 .

Molecular modeling studies on 11β-aminoethoxyphenyl and 7α-aminoethoxyphenyl estradiols. evidence suggesting a common hydrophobic pocket in estrogen receptor

J. Poupaert, J. Vamecq, D. Lambert, 1995 .

Latest advances in cannabinoid receptor antagonists and inverse agonists

G. Muccioli, D. Lambert, 2006 .

4-Nitro-N-phthalyl-l-tryptophan

B. Norberg, J. Wouters, D. Lambert, 2011, Acta crystallographica. Section E, Structure reports online.

A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors

G. Bormans, V. Baekelandt, K. Van Laere, 2011, The Journal of Nuclear Medicine.

GLP-2-driven improvement of gut permeability obese mice through a mechanism involving Changes in gut microbiota control inflammation in

T. Wiele, D. Naslain, A. Neyrinck, 2009 .

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

J. Wouters, B. Masereel, L. Pochet, 1998, Journal of medicinal chemistry.

Analgesic potency of S-acetylthiorphan after intravenous administration to mice.

J. Poupaert, D. Lambert, P. Dumont, 1993, European journal of pharmacology.

N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.

G. Scriba, J. Poupaert, D. Lambert, 1998, Journal of medicinal chemistry.

Synthesis and distribution of N‐benzyloxycarbonyl‐[14C]‐glycine, a lipophilic derivative of glycine

B. Gallez, D. Lambert, Jacques Poupaert, 1995 .

1,3‐Diacylaminopropan‐2‐ols and Corresponding 2‐Acyl Derivatives as Drug Carriers: Unexpected Pharmacological Properties

J. Poupaert, B. Gallez, D. Lambert, 1993, The Journal of pharmacy and pharmacology.

Antiepileptic activity of 1,3‐dihexadecanoylamino‐2‐valproyl‐propan‐2‐ol, a prodrug of valproic acid endowed with a tropism for the central nervous system

J. Poupaert, D. Lambert, P. Dumont, 1991, The Journal of pharmacy and pharmacology.

Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.

G. Ortar, D. Lambert, G. Labar, 2012, Bioorganic & medicinal chemistry.

Synthesis of 1,3-diacylaminopropan-2-ols and corresponding 2-acyl derivatives as amide isosteres of natural lipids.

J. Poupaert, D. Lambert, P. Dumont, 1991, Chemistry and physics of lipids.

AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide

C. Fowler, S. Vandevoorde, D. Lambert, 2003, Archives of Toxicology.

CB1 cannabinoid receptor antagonism for treating inflammation and arthritis

D. Lambert, 2007 .

Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration.

J. Poupaert, J. Maloteaux, D. Lambert, 1994, Neuroreport.

Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice[S]

M. Maillot, F. Destaillats, J. Martin, 2011, Journal of Lipid Research.

CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay

G. Muccioli, D. Lambert, G. Labar, 2008, Chembiochem : a European journal of chemical biology.

Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.

J. Poupaert, G. Muccioli, D. Lambert, 2009, Journal of medicinal chemistry.

Molecular Identification of N-Acetylaspartylglutamate Synthase and β-Citrylglutamate Synthase*

F. Opperdoes, F. Collard, J. Poupaert, 2010, The Journal of Biological Chemistry.

N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.

C. Fowler, S. Vandevoorde, D. Smart, 2003, Bioorganic & medicinal chemistry.

The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

D. Lambert, Di Marzo, 1999, Current medicinal chemistry.

An unprecedented reversible mode of action of β-lactams for the inhibition of human fatty acid amide hydrolase (hFAAH).

C. Michaux, D. Lambert, Marion Feledziak, 2013, European journal of medicinal chemistry.

beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.

C. Michaux, G. Muccioli, D. Lambert, 2009, Journal of medicinal chemistry.